Nature MedicinePub Date : 2026-05-07DOI: 10.1038/s41591-026-04427-1
{"title":"ChatGPT Health triage advice falls short in key cases.","authors":"","doi":"10.1038/s41591-026-04427-1","DOIUrl":"https://doi.org/10.1038/s41591-026-04427-1","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-05DOI: 10.1038/s41591-026-04403-9
{"title":"Autonomous pathology research using agentic AI shows potential in oncology.","authors":"","doi":"10.1038/s41591-026-04403-9","DOIUrl":"https://doi.org/10.1038/s41591-026-04403-9","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-05DOI: 10.1038/s41591-026-04437-z
Brendon L Neuen, Rupert W Major, Morgan E Grams, Yingying Sang, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Arnlov, Clare Arnott, Samira Bell, Jarett Berry, Hermann Brenner, Elizabeth Ciemins, Alexander R Chang, Mary Cushman, James A de Lemos, Juan Miguel Diaz-Tocados, Alfredo E Farjat, Robert A Fletcher, Ron T Gansevoort, Hiddo J L Heerspink, William G Herrington, Chuan Hong, Edward J Horwitz, Shih-Jen Hwang, Simerjot K Jassal, Philip A Kalra, Ronit Katz, Sadiya S Khan, Csaba P Kovesdy, Florian Kronenberg, Jennifer S Lees, Donald M Lloyd-Jones, Jose Geraldo Mill, David M J Naimark, Chiadi Ndumele, Kevan R Polkinghorne, Bruce M Psaty, Patrick Schloemer, Michael Shlipak, Prabin Shrestha, Zean Song, Natalie Staplin, Dominik Steubl, Priya Vart, Frank L J Visseren, Mark Woodward, Kazumasa Yamagishi, Bessie A Young, Charumathi Sabanayagam, Jose M Valdivielso
{"title":"Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.","authors":"Brendon L Neuen, Rupert W Major, Morgan E Grams, Yingying Sang, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Arnlov, Clare Arnott, Samira Bell, Jarett Berry, Hermann Brenner, Elizabeth Ciemins, Alexander R Chang, Mary Cushman, James A de Lemos, Juan Miguel Diaz-Tocados, Alfredo E Farjat, Robert A Fletcher, Ron T Gansevoort, Hiddo J L Heerspink, William G Herrington, Chuan Hong, Edward J Horwitz, Shih-Jen Hwang, Simerjot K Jassal, Philip A Kalra, Ronit Katz, Sadiya S Khan, Csaba P Kovesdy, Florian Kronenberg, Jennifer S Lees, Donald M Lloyd-Jones, Jose Geraldo Mill, David M J Naimark, Chiadi Ndumele, Kevan R Polkinghorne, Bruce M Psaty, Patrick Schloemer, Michael Shlipak, Prabin Shrestha, Zean Song, Natalie Staplin, Dominik Steubl, Priya Vart, Frank L J Visseren, Mark Woodward, Kazumasa Yamagishi, Bessie A Young, Charumathi Sabanayagam, Jose M Valdivielso","doi":"10.1038/s41591-026-04437-z","DOIUrl":"https://doi.org/10.1038/s41591-026-04437-z","url":null,"abstract":"<p><p>The American Heart Association's PREVENT equations estimate risk of total cardiovascular disease (CVD), atherosclerotic CVD (ASCVD), and heart failure (HF) to guide lipid and blood pressure-lowering therapy in people ages 30 to 79 years in the United States. The SCORE2 risk algorithm is used to estimate CVD risk for similar purposes in people ages 40 and older in Europe. Neither set of equations has been comprehensively validated in global observational cohorts and randomized trials. Here, in 44 observational cohorts and 18 randomized trials, we assessed discrimination and calibration of the two risk algorithms across geographical regions (North America, Europe, Asia/other, multi-region trials). We also created scaling factors for risk prediction over 1-9 years using the PREVENT equations, enabling shorter-term risk prediction for research purposes or to facilitate clinical trial enrolment. Over 5.1 years of mean follow-up, 293,737 PREVENT total CVD events (fatal and non-fatal ASCVD or HF) and 258,086 SCORE2 CVD events (myocardial infarction, stroke, or cardiovascular death) were observed among 6,422,714 and 5,437,384 individuals, respectively. Despite differences in CVD outcome definitions, target populations and predictor variables, overall discrimination and calibration were similar for both equations, with generally good performance across regions, including in multi-regional randomized trials. These findings lend support for adoption of PREVENT or SCORE2 for cardiovascular risk stratification across diverse settings.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-05DOI: 10.1038/s41591-026-04425-3
Princess U Ogbogu, Florence Roufosse, Praveen Akuthota, Piotr Kuna, Matthieu Groh, Andreas Reiter, Akira Yokota, Salman H Siddiqui, Pim G N J Mutsaers, Bing Li, Paneez Khoury, Lila M Bahadori, Artur Bednarczyk, Gerben Bouma, Laura G Brooks, Jorge Ferreira, Hanna Grindebacke, Calvin N Ho, Priya Jain, Rebecca L Palmer, Maria L Jison, Amy D Klion
{"title":"Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.","authors":"Princess U Ogbogu, Florence Roufosse, Praveen Akuthota, Piotr Kuna, Matthieu Groh, Andreas Reiter, Akira Yokota, Salman H Siddiqui, Pim G N J Mutsaers, Bing Li, Paneez Khoury, Lila M Bahadori, Artur Bednarczyk, Gerben Bouma, Laura G Brooks, Jorge Ferreira, Hanna Grindebacke, Calvin N Ho, Priya Jain, Rebecca L Palmer, Maria L Jison, Amy D Klion","doi":"10.1038/s41591-026-04425-3","DOIUrl":"https://doi.org/10.1038/s41591-026-04425-3","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-04DOI: 10.1038/s41591-026-04375-w
Bilal A Mateen
{"title":"An international and independent scientific foundation for AI governance.","authors":"Bilal A Mateen","doi":"10.1038/s41591-026-04375-w","DOIUrl":"https://doi.org/10.1038/s41591-026-04375-w","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-01DOI: 10.1038/s41591-026-04387-6
Mihir R Atreya, Luregn J Schlapbach
{"title":"Rethinking triage for febrile children in low-resource settings.","authors":"Mihir R Atreya, Luregn J Schlapbach","doi":"10.1038/s41591-026-04387-6","DOIUrl":"https://doi.org/10.1038/s41591-026-04387-6","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147818095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-05-01DOI: 10.1038/s41591-026-04373-y
Emilia M Jalil, Valdiléa G Veloso, Beatriz Grinsztejn
{"title":"Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems.","authors":"Emilia M Jalil, Valdiléa G Veloso, Beatriz Grinsztejn","doi":"10.1038/s41591-026-04373-y","DOIUrl":"https://doi.org/10.1038/s41591-026-04373-y","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147817966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nature MedicinePub Date : 2026-04-30DOI: 10.1038/d41591-026-00025-3
Carrie Arnold
{"title":"At last, a pipeline for treating kidney disease.","authors":"Carrie Arnold","doi":"10.1038/d41591-026-00025-3","DOIUrl":"10.1038/d41591-026-00025-3","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147817948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}